Dorzolamide: A highly soluble topical carbonic anhydrase inhibitor that permeates the cornea to target CA-II in the ciliary body, effectively reducing elevated intraocular pressure associated with open-angle glaucoma.
Indications
Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma
Management of ocular hypertension
Note: This is an indicative Indication, please follow the doctors advise. Do not self medicate.
Dosage & Administration
Instill 1 drop into the inferior conjunctival cul-de-sac of the affected eye(s) as prescribed by the physician. Dosing frequency should be adjusted according to clinical response and severity.
Note: This is an indicative dosage, please follow the doctors advise. Do not self medicate.
References
1. Strahlman E, et al. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol. Ophthalmology. 1996;103(8):1283-1293.
2. Hutzelmann J, et al. A comparison of dorzolamide and timolol in patients with open-angle glaucoma. Ophthalmology. 1998;105(3):524-529.
Warning: This information is only for the use of registered medical practitioners only.
Certified Manufacturing Standards
Disclaimer: This content is compiled from various references. We do not endorse any of it. Readers are advised not to self-medicate and to follow a doctor’s prescription and guidance.